CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Catheter ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04022954
NCT04022954N/ACompleted
CompareCT.gov

HD Mapping Observational Study - Asia Pacific

Abbott Medical Devices·observational·Posted Jul 17, 2019·Updated Mar 29, 2024

In Brief

An observational study evaluating Catheter ablation for Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation. Completed, enrolled 200 participants across 15 sites in 5 countries.

Detailed Summary

The aim of this study is to quantify and characterize the outcomes of radiofrequency (RF) ablation after, and the utility of, electroanatomical mapping with the market-released HD mapping catheters Inquiry™ AFocusII™ Double Loop and Advisor™ HD Grid, Sensor Enabled™ with the EnSite Cardiac Mapping System and the EnSite Automap module in subjects with AF in the real-world environment of the Asian population.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
CountriesChina, Hong Kong, Japan, South Korea, Taiwan
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 17, 2019
Enrollment StartSep 11, 2019
Primary CompletionAug 13, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.0 years ago

Interventions

Catheter ablationdevice

Inquiry AFocusII Double Loop and Advisor HD Grid, Sensor Enabled